Clari Vest Asset Management LLC Curis Inc Transaction History

Clari Vest Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.71 - $2.43 $75,913 - $259,815	-106,920 Closed	0 $0
Q1 2022 May 04, 2022	SELL	$2.31 - $5.13 $36,036 - $80,028	-15,600 Reduced 12.73%	106,920 $255,000
Q4 2021 Feb 14, 2022	BUY	$4.45 - $8.09 $84,505 - $153,629	18,990 Added 18.34%	122,520 $584,000
Q3 2021 Nov 08, 2021	SELL	$6.94 - $8.85 $2,012 - $2,566	-290 Reduced 0.28%	103,530 $810,000
Q2 2021 Aug 09, 2021	BUY	$7.45 - $16.27 $773,459 - $1.69 Million	103,820 New	103,820 $837,000

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $409M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Clari Vest Asset Management LLC with notifications on news.